DICLOPLAST

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
DICLOFENAC SODIUM
Available from:
CTS LTD
ATC code:
M02AA15
Pharmaceutical form:
PATCHES
Composition:
DICLOFENAC SODIUM 140 MG
Administration route:
TOPICAL
Prescription type:
Not required
Manufactured by:
IBSA INSTITUTE BIOCHIMIQUE SA, SWITZERLAND
Therapeutic group:
DICLOFENAC
Therapeutic area:
DICLOFENAC
Therapeutic indications:
Dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.
Authorization number:
129 72 28525 01
Authorization date:
2013-12-31

Documents in other languages

Patient Information leaflet Patient Information leaflet - Hebrew

17-08-2016

Similar products

Search alerts related to this product

View documents history

Share this information